August 13th 2020EP. 1: An Overview of Myelodysplastic Syndrome
August 13th 2020EP. 2: Understanding Myelodysplastic Syndrome's Nature as Cancer
August 13th 2020EP. 3: Myelodysplastic Syndrome: Diagnosis and Risk Stratification
August 13th 2020EP. 4: Clinical Burden of Myelodysplastic Syndrome
August 13th 2020EP. 5: Economic Burden of Myelodysplastic Syndrome
August 13th 2020EP. 6: Myelodysplastic Syndrome: Goals of Therapy
August 13th 2020EP. 7: MDS Management: Use of Bone Marrow Transplantation
August 13th 2020EP. 8: Therapies and Treatment Regimens for MDS
August 13th 2020EP. 9: Hypomethylating Agents in MDS Management
August 13th 2020EP. 10: MDS Management: Use of Transfusion Alongside HMAs
August 13th 2020EP. 11: Potential Complications of Transfusions in MDS Management
August 13th 2020EP. 12: MDS Management: Challenges With Chemotherapy
August 13th 2020EP. 13: MDS Management: ASCERTAIN Equivalence Study
August 13th 2020EP. 14: Oral HMAs in MDS Management: Adherence and Accessibility
August 13th 2020EP. 15: Oral HMAs in MDS: Personal Experience and Future Directions
August 13th 2020EP. 16: MDS: Access to Care and Other Ongoing Challenges
August 13th 2020EP. 17: Practical Advice for Managing Myelodysplastic Syndrome
